Merck & Co., Inc.
MRK
Clasificación en acciones
#40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Precio por acción
$145.90
Última sincronización: 2026-10-16
Capitalización bursátil
$359.96B
Cambio (1 día)
0.16%
Cambio (1 año)
72.07%
País
US
Comercio Merck & Co., Inc. (MRK)
Categoría
Healthcare
Margen Operativo de Merck & Co., Inc. (MRK)
Margen Operativo al October 2026 TTM: 16.65%
Según los informes financieros más recientes y el precio de las acciones de Merck & Co., Inc., el margen operativo actual (TTM) es 16.65%. Al final de 2024, el margen operativo era 31.51%.
Historial de Margen Operativo de Merck & Co., Inc. desde 2000 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | 16.65% | -59.58% |
| 2025 | 41.19% | 30.72% |
| 2024 | 31.51% | 541.75% |
| 2023 | 4.91% | -84.08% |
| 2022 | 30.84% | 13.80% |
| 2021 | 27.10% | 102.84% |
| 2020 | 13.36% | -34.06% |
| 2019 | 20.26% | -4.07% |
| 2018 | 21.12% | 24.68% |
| 2017 | 16.94% | 22.66% |
| 2016 | 13.81% | -27.73% |
| 2015 | 19.11% | 20.80% |
| 2014 | 15.82% | -9.13% |
| 2013 | 17.41% | -16.70% |
| 2012 | 20.90% | 11.88% |
| 2011 | 18.68% | 155.89% |
| 2010 | 7.30% | -50.20% |
| 2009 | 14.66% | -42.53% |
| 2008 | 25.51% | 9.86% |
| 2007 | 23.22% | 42.54% |
| 2006 | 16.29% | -38.81% |
| 2005 | 26.62% | -9.52% |
| 2004 | 29.42% | -22.80% |
| 2003 | 38.11% | -10.08% |
| 2002 | 42.38% | -3.18% |
| 2001 | 43.77% | 94.36% |
| 2000 | 22.52% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 49.72% | -97.01% |
US
|
|
| 25.70% | -98.46% |
US
|
|
| 29.32% | -98.24% |
US
|
|
| 26.59% | -98.40% |
CH
|
|
| 31.24% | -98.12% |
CH
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.